Loading insider details...
Latest Form 4 (Nov 6, 2026): Sale of 25,000 XERS shares, $312.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 6, 2026 | Xeris Biopharma Holdings, Inc. (XERS) | Sale | 25,000 | $312.2K |
| Nov 4, 2026 | Xeris Biopharma Holdings, Inc. (XERS) | Sale | 15,000 | $153.5K |
| Oct 2, 2026 | Xeris Biopharma Holdings, Inc. (XERS) | Sale | 15,000 | $141.1K |
| Sep 29, 2026 | Xeris Biopharma Holdings, Inc. (XERS) | Sale | 25,000 | $250.0K |
| Sep 1, 2026 | Xeris Biopharma Holdings, Inc. (XERS) | Sale | 15,000 | $127.3K |
| Aug 21, 2026 | Xeris Biopharma Holdings, Inc. (XERS) | Tax Withholding | 21,918 | $177.1K |
| Aug 4, 2026 | Xeris Biopharma Holdings, Inc. (XERS) | Sale | 15,000 | $120.2K |
| Jul 2, 2026 | Xeris Biopharma Holdings, Inc. (XERS) | Sale | 90,000 | $722.5K |
| Mar 16, 2026 | Xeris Biopharma Holdings, Inc. (XERS) | Exercise/Conversion | 48,894 | $200.0K |
| Feb 2, 2026 | Xeris Biopharma Holdings, Inc. (XERS) | Grant/Award | 168,463 | n/a |